-
1
-
-
0004235298
-
-
American Psychiatric Association APA, Third Edition, Revised: DSM-III-R. Arlington, VA: American Psychiatric Association
-
American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised: DSM-III-R. Arlington, VA: American Psychiatric Association, 1987.
-
(1987)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
2
-
-
58649101333
-
Integrating buprenorphine treatment into office-based practice: A qualitative study
-
Barry DT, Irwin KS, Jones ES, et al. Integrating buprenorphine treatment into office-based practice: a qualitative study. J Gen Intern Med 2009;24:218-225.
-
(2009)
J Gen Intern Med
, vol.24
, pp. 218-225
-
-
Barry, D.T.1
Irwin, K.S.2
Jones, E.S.3
-
3
-
-
0031304840
-
The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence
-
Cacciola JS, Alterman AI, O'Brien CP, et al. The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence. NIDA Res Monogr 1997;175:182-191.
-
(1997)
NIDA Res Monogr
, vol.175
, pp. 182-191
-
-
Cacciola, J.S.1
Alterman, A.I.2
O'Brien, C.P.3
-
4
-
-
4644372400
-
Consensus statement on office-based treatment of opioid dependence using buprenorphine
-
Fiellin DA, Kleber H, Trumble-Hejduk JG, et al. Consensus statement on office-based treatment of opioid dependence using buprenorphine. J Subst Abuse Treat 2004;27:153-159.
-
(2004)
J Subst Abuse Treat
, vol.27
, pp. 153-159
-
-
Fiellin, D.A.1
Kleber, H.2
Trumble-Hejduk, J.G.3
-
5
-
-
0032877350
-
Buprenorphine versus methadone maintenance for the treatment of opioid dependence
-
Fischer G, Gombas W, Eder H, et al. Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 1999;94:1337-1347.
-
(1999)
Addiction
, vol.94
, pp. 1337-1347
-
-
Fischer, G.1
Gombas, W.2
Eder, H.3
-
6
-
-
62649093043
-
Understanding attitudes toward use of medication in substance abuse treatment: A multilevel approach
-
Fitzgerald J, McCarty D. Understanding attitudes toward use of medication in substance abuse treatment: a multilevel approach. Psychol Serv 2009;6:74-84.
-
(2009)
Psychol Serv
, vol.6
, pp. 74-84
-
-
Fitzgerald, J.1
McCarty, D.2
-
7
-
-
0042360208
-
Office-based treatment of opioid addiction with a sublingual-tablet formulation of buprenorphine and naloxone
-
Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opioid addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med 2003;349:949-958.
-
(2003)
N Engl J Med
, vol.349
, pp. 949-958
-
-
Fudala, P.J.1
Bridge, T.P.2
Herbert, S.3
-
9
-
-
0028827422
-
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence
-
Johnson RE, Eissenberg T, Stitzer ML, et al. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend 1995;40:17-25.
-
(1995)
Drug Alcohol Depend
, vol.40
, pp. 17-25
-
-
Johnson, R.E.1
Eissenberg, T.2
Stitzer, M.L.3
-
10
-
-
0037460743
-
1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial
-
Kakko J, Svanborg KD, Kreek MJ, et al. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet 2003;361:662-668.
-
(2003)
Lancet
, vol.361
, pp. 662-668
-
-
Kakko, J.1
Svanborg, K.D.2
Kreek, M.J.3
-
11
-
-
15444361736
-
Buprenorphine maintenance treatment of opioid dependence: A multicenter, randomized clinical trial
-
Ling W, Charuvastra C, Collins JF, et al. Buprenorphine maintenance treatment of opioid dependence: a multicenter, randomized clinical trial. Addiction 1998;93:478-486.
-
(1998)
Addiction
, vol.93
, pp. 478-486
-
-
Ling, W.1
Charuvastra, C.2
Collins, J.F.3
-
12
-
-
0031297893
-
Treatment effectiveness score as an outcome measure in clinical trials
-
Ling W, Shoptaw S, Wesson D, et al. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res Monogr 1997;172:208-220.
-
(1997)
NIDA Res Monogr
, vol.172
, pp. 208-220
-
-
Ling, W.1
Shoptaw, S.2
Wesson, D.3
-
13
-
-
0037394666
-
Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients
-
Mattick RP, Ali R, White JM, et al. Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients. Addiction 2003;98:441-452.
-
(2003)
Addiction
, vol.98
, pp. 441-452
-
-
Mattick, R.P.1
Ali, R.2
White, J.M.3
-
15
-
-
34047148797
-
Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings
-
Mintzer IL, Eisenberg M, Terra M, et al. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med 2007:146-150.
-
(2007)
Ann Fam Med
, pp. 146-150
-
-
Mintzer, I.L.1
Eisenberg, M.2
Terra, M.3
-
16
-
-
34250222503
-
Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients
-
Moore BA, Fiellin DA, Barry DT, et al. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med 2007;22:527-530.
-
(2007)
J Gen Intern Med
, vol.22
, pp. 527-530
-
-
Moore, B.A.1
Fiellin, D.A.2
Barry, D.T.3
-
17
-
-
34347233453
-
The impact of self-help group attendance on relapse rates after alcohol detoxification in a controlled study
-
Mueller SE, Petitjean S, Boening J, et al. The impact of self-help group attendance on relapse rates after alcohol detoxification in a controlled study. Alcohol Alcohol 2007;42:108-112.
-
(2007)
Alcohol Alcohol
, vol.42
, pp. 108-112
-
-
Mueller, S.E.1
Petitjean, S.2
Boening, J.3
-
18
-
-
33749530075
-
Contingency management for treatment of substance use disorders: A meta-analysis
-
Prendergast M, Podus D, Finney J, et al. Contingency management for treatment of substance use disorders: a meta-analysis. Addiction 2006;101:1546-1560.
-
(2006)
Addiction
, vol.101
, pp. 1546-1560
-
-
Prendergast, M.1
Podus, D.2
Finney, J.3
-
19
-
-
33748706149
-
Patterns of organization and management in private and public substance abuse treatment programs
-
Roman PM, Ducharme LJ, Knudsen HK. Patterns of organization and management in private and public substance abuse treatment programs. J Subst Abuse Treat 2006;31:235-243.
-
(2006)
J Subst Abuse Treat
, vol.31
, pp. 235-243
-
-
Roman, P.M.1
Ducharme, L.J.2
Knudsen, H.K.3
-
20
-
-
0037333968
-
Probable relationship between opioid abuse and heroin use
-
Siegal HA, Carlson RG, Kenne DR, et al. Probable relationship between opioid abuse and heroin use. Am Fam Phys 2003;67(942):945.
-
(2003)
Am Fam Phys
, vol.67
, Issue.942
, pp. 945
-
-
Siegal, H.A.1
Carlson, R.G.2
Kenne, D.R.3
-
21
-
-
34248372424
-
I love you... and heroin: Care and collusion among drug-using couples
-
Simmons J, Singer M. I love you... and heroin: care and collusion among drug-using couples. Subst Abuse Treat Prev Policy 2006;1:7.
-
(2006)
Subst Abuse Treat Prev Policy
, vol.1
, pp. 7
-
-
Simmons, J.1
Singer, M.2
-
23
-
-
1242312410
-
-
Substance Abuse and Mental Health Service Administration, Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774, Rockville, MD
-
Substance Abuse and Mental Health Service Administration. (2003). Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774). Rockville, MD.
-
(2003)
Overview of Findings from the 2002 National Survey on Drug use and Health
-
-
-
24
-
-
84859681143
-
-
Accessed March 2010
-
Substance Abuse and Mental Health Service Administration. Evaluation of the Buprenorphine Waiver Program. 2006. Available at: http://buprenorphine. samhsa.gov/evaluation. html. Accessed March 2010.
-
(2006)
Evaluation of the Buprenorphine Waiver Program
-
-
-
25
-
-
0344880457
-
-
October 8, Subutex and Suboxone approved to treat opiate dependence
-
U. S. Food and Drug Administration. FDA Talk Paper, T0238. October 8, 2002. Subutex and Suboxone approved to treat opiate dependence. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafety InformationforPatientsandProviders/ucm191521.htm.
-
(2002)
FDA Talk Paper, T0238
-
-
|